Exporter

EN
FR
Vinblastine
Statut de médicament essentiel
Description générale

INN
Vinblastine
Codes ATC
L01CA01
Type de médicament
Chemical agent
Historique des statuts LME
Ajouté en 2015 (TRS 994) pour Hodgkin lymphoma
Ajouté en 2015 (TRS 994) pour Germ cell tumour of testis
Wikipédia
Vinblastine
DrugBank
Vinblastine
Recommandations
Section
Cytotoxic medicines
  • Parenteral > General injections > IV: 10 mg in vial (vinblastine sulfate); 10 mg per 10 mL in vial (vinblastine sulfate)
  • Parenteral > General injections > IV: 10 mg in vial (vinblastine sulfate)
Indications
Hodgkin lymphoma Kaposi sarcoma of unspecified primary site Germ cell tumour of testis Other specified malignant neoplasms of the ovary Unspecified malignant neoplasms of ill-defined or unspecified sites Other specified gliomas of brain Anaplastic large cell lymphoma, ALK-positive Anaplastic large cell lymphoma, ALK-negative Langerhans cell histiocytosis